Triazolam

三唑仑

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameTriazolam
Drug Alias Name三唑苯二氮Triazolamum酣乐欣HypnostatHalcion +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Global Approved IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Approved Indications in ChinaSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date1982/11/15
Country/TerritoryBelgiumUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Japan IncJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance DisordersAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN05CD05
Related LinksWikipediaDrugBankKEGG